Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule.

C Sessa; K Weigang-Köhler; O Pagani; G Greim; O Mora; T De Pas; M Burgess; I Weimer; R Johnson

doi:10.1016/S0959-8049(02)00489-6

Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule.

C Sessa
, K Weigang-Köhler
, O Pagani
, G Greim
, O Mora
, T De Pas
, M Burgess
, I Weimer
, R Johnson

Universitätsklinik für Innere Medizin 5 - Onkologie und Hämatologie

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

53 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	2388-2396
Fachzeitschrift	EUROPEAN JOURNAL OF CANCER
Jahrgang	38
Ausgabenummer	18
DOIs	https://doi.org/10.1016/S0959-8049(02)00489-6
Publikationsstatus	Veröffentlicht - 2002

Zugriff auf Dokument

10.1016/S0959-8049(02)00489-6

Dieses zitieren

Sessa, C., Weigang-Köhler, K., Pagani, O., Greim, G., Mora, O., De Pas, T., Burgess, M., Weimer, I., & Johnson, R. (2002). Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule. EUROPEAN JOURNAL OF CANCER , 38(18), 2388-2396. https://doi.org/10.1016/S0959-8049(02)00489-6

Sessa, C ; Weigang-Köhler, K ; Pagani, O et al. / Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule. in: EUROPEAN JOURNAL OF CANCER 2002 ; Jahrgang 38, Nr. 18. S. 2388-2396.

@article{0b3c875e010549228615d260b48f6b28,

title = "Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule.",

keywords = "PACLITAXEL, MECHANISM, BINDING",

author = "C Sessa and K Weigang-K{\"o}hler and O Pagani and G Greim and O Mora and \{De Pas\}, T and M Burgess and I Weimer and R Johnson",

year = "2002",

doi = "10.1016/S0959-8049(02)00489-6",

language = "English",

volume = "38",

pages = "2388--2396",

journal = "EUROPEAN JOURNAL OF CANCER ",

issn = "0959-8049",

publisher = "Elsevier ",

number = "18",

}

Sessa, C, Weigang-Köhler, K, Pagani, O, Greim, G, Mora, O, De Pas, T, Burgess, M, Weimer, I & Johnson, R 2002, 'Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule.', EUROPEAN JOURNAL OF CANCER , Jg. 38, Nr. 18, S. 2388-2396. https://doi.org/10.1016/S0959-8049(02)00489-6

Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule. / Sessa, C; Weigang-Köhler, K; Pagani, O et al.
in: EUROPEAN JOURNAL OF CANCER , Jahrgang 38, Nr. 18, 2002, S. 2388-2396.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule.

AU - Sessa, C

AU - Weigang-Köhler, K

AU - Pagani, O

AU - Greim, G

AU - Mora, O

AU - De Pas, T

AU - Burgess, M

AU - Weimer, I

AU - Johnson, R

PY - 2002

Y1 - 2002

KW - PACLITAXEL

KW - MECHANISM

KW - BINDING

U2 - 10.1016/S0959-8049(02)00489-6

DO - 10.1016/S0959-8049(02)00489-6

M3 - Original Article

C2 - 12460783

SN - 0959-8049

VL - 38

SP - 2388

EP - 2396

JO - EUROPEAN JOURNAL OF CANCER

JF - EUROPEAN JOURNAL OF CANCER

IS - 18

ER -

Sessa C, Weigang-Köhler K, Pagani O, Greim G, Mora O, De Pas T et al. Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule. EUROPEAN JOURNAL OF CANCER . 2002;38(18):2388-2396. doi: 10.1016/S0959-8049(02)00489-6